Previous 10 | Next 10 |
2024-02-25 18:50:34 ET More on Enovis Corporation, Paragon 28, etc. Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.05, revenue of $455.02M beats by $9.63M Enovis Corporation Q4 2023 Earnings Preview ...
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024 PR Newswire WARSAW, Ind. , Feb. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has app...
2024-02-13 00:39:21 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity PR Newswire -- Company's Recently Established Health Equity Division Leads Efforts to Address Disparities in Health Access and Outcomes -- ...
Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting PR Newswire -- Booth Highlights Include Persona ® OsseoTi ® Keel Tibia, a Preview of ROSA ® Shoulder * , Pending 510(k) Clearance, and the HAMMR...
2024-02-09 13:30:02 ET Raymond James analyst issues UNDERPERFORM recommendation for ZBH on February 9, 2024 01:00PM ET. The previous analyst recommendation was Underperform. ZBH was trading at $121.57 at issue of the analyst recommendation. The overall analyst consensus ...
2024-02-09 13:30:02 ET RBC Capital analyst issues EQUAL-WEIGHT recommendation for ZBH on February 9, 2024 01:00PM ET. The previous analyst recommendation was Equal-Weight. ZBH was trading at $121.57 at issue of the analyst recommendation. The overall analyst consensus : ...
(NewsDirect) Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solution...
2024-02-08 13:15:22 ET Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Conference Call February 8, 2024, 8:30 am ET Company Participants Keri Mattox - Chief Communications & Administration Officer Ivan Tornos - President & CEO Suky Upadhyay - CFO &...
2024-02-08 06:34:01 ET More on Zimmer Biomet Zimmer Biomet: Weight Loss Drug Concerns Are Overblown Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy' Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution Zimmer Bio...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
2024-05-30 08:00:06 ET Shagun Singh from RBC Capital issued a price target of $140.00 for ZBH on 2024-05-30 06:24:00. The adjusted price target was set to $140.00. At the time of the announcement, ZBH was trading at $115.14. The overall price target consensus is at $142....
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day PR Newswire Presents Path for Compelling and Durable Topline Growth, Improved Operational Profitability and Increased Free Cash Flow Generation Details New Capital Allocation Priorities...
2024-05-28 07:30:06 ET BTIG analyst issues BUY recommendation for ZBH on May 28, 2024 05:32AM ET. The previous analyst recommendation was Buy. ZBH was trading at $116.41 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst rec...